DE-120

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameDE-120

Drug Alias NameDE-120

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet-derived growth factor subunit A inhibitorsVascular endothelial growth factor A inhibitorsPlatelet-derived growth factor subunit B inhibitors

TargetsPlatelet-derived growth factor subunit BPlatelet-derived growth factor subunit AVascular endothelial growth factor A

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanten

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanten Inc

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A